Huichan He

2.2k total citations
79 papers, 1.7k citations indexed

About

Huichan He is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huichan He has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 24 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huichan He's work include Prostate Cancer Treatment and Research (17 papers), Signaling Pathways in Disease (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Huichan He is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Signaling Pathways in Disease (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Huichan He collaborates with scholars based in China, United States and Macao. Huichan He's co-authors include Weide Zhong, Zhaodong Han, Qi-Shan Dai, Yuxiang Liang, Funeng Jiang, Xue‐cheng Bi, Chao Cai, Zhuoyuan Lin, Guohua Zeng and Yongkang Ye and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Huichan He

76 papers receiving 1.6k citations

Peers

Huichan He

PRM

ONCOL

IMMUN

Kwang‐Yu Chang Taiwan

Jianming Hu China

Ming Song China

Eri Arai Japan

Niranjan Awasthi United States

Kan Gong China

Chuanyuan Wei China

Quintin Pan United States

Dongjun Jeong South Korea

Qiong Shao China

Kwang‐Yu Chang Taiwan

Huichan He

772 ×0.7

393 ×0.6

207 ×0.5

PRM

328 ×0.9

ONCOL

137 ×0.8

IMMUN

Citations per year, relative to Huichan He Huichan He (= 1×) peers Kwang‐Yu Chang

Countries citing papers authored by Huichan He

Since Specialization

Citations

This map shows the geographic impact of Huichan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huichan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huichan He more than expected).

Fields of papers citing papers by Huichan He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huichan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huichan He. The network helps show where Huichan He may publish in the future.

Co-authorship network of co-authors of Huichan He

This figure shows the co-authorship network connecting the top 25 collaborators of Huichan He. A scholar is included among the top collaborators of Huichan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huichan He. Huichan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shaoyou, Jian Chen, Xinyue Mei, et al.. (2025). ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer. Cell Communication and Signaling. 23(1). 352–352.

Xie, Wenjie, Zhihao Zou, Yuting Zhang, et al.. (2024). Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation‐Caused Quenching. SHILAP Revista de lepidopterología. 6(3). 7 indexed citations

Xie, Wenjie, Yuting Zhang, Guowei Zhong, et al.. (2024). A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy. International Journal of Nanomedicine. Volume 19. 3957–3972. 9 indexed citations

Zou, Zhihao, Zhengrong Zhang, Huichan He, et al.. (2024). Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC. Cancer Letters. 605. 217286–217286. 5 indexed citations

Han, Rui, Huichan He, Mingjian Liang, et al.. (2024). Investigation of the correlation between platelet antibodies and peripheral blood cytopenia in patients with hepatocellular carcinoma. Scientific Reports. 14(1). 9705–9705.

Luo, Hongwei, Huichan He, Zezhen Liu, et al.. (2024). Identifying CDCA3 as a pivotal biomarker for predicting outcomes and immunotherapy efficacy in pan-renal cell carcinoma. Translational Andrology and Urology. 13(9). 1955–1970. 1 indexed citations

Ye, Jian‐Heng, Yuanfa Feng, Zhiduan Cai, et al.. (2023). Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal Transduction and Targeted Therapy. 8(1). 303–303. 12 indexed citations

He, Huichan, et al.. (2022). Circulating Epstein-Barr virus DNA associated with hepatic impairment and its diagnostic and prognostic role in patients with gastric cancer. Frontiers in Medicine. 9. 1028033–1028033. 2 indexed citations

Su, Xuan, Huichan He, Zu‐Lu Ye, et al.. (2020). A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers. Frontiers in Oncology. 10. 535893–535893. 10 indexed citations

10.

Jia, Zhenyu, Jianguo Zhu, Yangjia Zhuo, et al.. (2019). Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment. Frontiers in Oncology. 9. 539–539. 7 indexed citations

11.

Lü, Jianming, Weimin Dong, Huichan He, et al.. (2018). Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer. International Journal of Biological Macromolecules. 118(Pt A). 599–609. 32 indexed citations

12.

Liang, Yingke, Yanqiong Zhang, Zhaodong Han, et al.. (2017). Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer. Tumor Biology. 39(6). 3726131992–3726131992. 12 indexed citations

13.

Liang, Yuxiang, Jianming Lü, Rujun Mo, et al.. (2016). E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer. International Journal of Oncology. 48(4). 1650–1658. 47 indexed citations

14.

Cai, Chao, Zhaodong Han, Yanqiong Zhang, et al.. (2015). miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Clinical Cancer Research. 21(21). 4922–4934. 103 indexed citations

15.

Fu, Hao, Huichan He, Zhaodong Han, et al.. (2014). MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer. Tumor Biology. 36(3). 1983–1991. 30 indexed citations

16.

Zhong, Weide, Huichan He, Zhaodong Han, et al.. (2014). Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer. OncoTargets and Therapy. 7. 137–137. 15 indexed citations

17.

Jiang, Funeng, Huichan He, Yanqiong Zhang, et al.. (2013). An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis. PLoS ONE. 8(5). e63941–e63941. 25 indexed citations

18.

Dai, Qi-Shan, Huichan He, Chao Cai, et al.. (2011). [Multicenter case-control study of the relationship between smoking and bladder cancer in China].. PubMed. 91(34). 2407–10. 6 indexed citations

19.

Cai, Chao, Funeng Jiang, Yuxiang Liang, et al.. (2011). Classical and Alternative Nuclear Factor-κB Pathways: A Comparison among Normal Prostate, Benign Prostate Hyperplasia and Prostate Cancer. Pathology & Oncology Research. 17(4). 873–878. 6 indexed citations

20.

Zhong, Weide, Yuxiang Liang, Sharron X. Lin, et al.. (2011). Expression of CD147 is associated with prostate cancer progression. International Journal of Cancer. 130(2). 300–308. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact